Crestline Management, LP Ironwood Pharmaceuticals Inc Transaction History

Crestline Management, LP

  • $2.93 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 12, 2020
SELL
$8.22 - $14.0 $1.15 Million - $1.96 Million
-140,000 Closed
0 $0
Q3 2019

Nov 13, 2019
BUY
$8.59 - $10.96 $1.2 Million - $1.53 Million
140,000 New
140,000 $1.2 Million
Q3 2018

Nov 14, 2018
SELL
$14.31 - $17.65 $437,886 - $540,090
-30,600 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$11.83 - $16.2 $361,998 - $495,720
30,600 New
30,600 $585,000

Others Institutions Holding IRWD

# of Institutions
242
Shares Held
163M
Call Options Held
11.5M
Put Options Held
12.9K
View Full List

About IRONWOOD PHARMACEUTICALS INC

IRWD Quotes by TradingView
  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $99.6M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Crestline Management, LP Portfolio

Follow Crestline Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crestline Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Crestline Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email